Category : Healthcare and Pharmaceuticals | Published at : September-2022 | Delivery Format : PDF | Status: Published | Pages : 250
The Global Kidney Dialysis Market Size accounted for USD 71.2 Billion in 2021 and is estimated to achieve a market size of USD 116.1 Billion by 2030 growing at a CAGR of 5.7% from 2022 to 2030. An aging and senior population, an increase in the number of people with kidney diseases, rising healthcare expenditures due to increased demand for diagnosis, and increasing disposable income in global markets are all factors influencing the expansion of the kidney dialysis market value. Furthermore, an increase in end-stage renal disease cases, an increase in the prevalence of long-term health concerns as a result of an unhealthy diet, and inheriting kidney disorders will push the global kidney dialysis market growth.
Kidney Dialysis Market Report Key Highlights
- Global kidney dialysis market revenue is expected to increase by USD 116.1 billion by 2030, with a 5.7% CAGR from 2022 to 2030
- According to the study, chronic kidney disease affects 10% of the world's population
- North America region leads the market with more than 35% share in 2021
- According to the NVS 2021 report, kidney disease affects approximately 37 million persons in the United States
- Among end-user, in-center dialysis settings sector occupied more than 75% of the total market share
- Asia-Pacific is projected to raise at a moderate pace and have a substantial market revenue share in 2021
Kidney dialysis is a procedure to remove waste products and excess fluid from the blood when the kidneys stop functioning. If kidneys are not functioning properly due to advanced chronic kidney disease (CKD) the kidneys are unable to clean the blood properly. Waste products and fluids can build dangerous levels in the body. If left untreated, it can cause a number of unpleasant symptoms and eventually be fatal. As per the statistics revealed by the Centers for Disease Control and Prevention (CDC), CKD is more common in people aged 65 years or older (38%) than in people aged 45-64 years (13%) or 18-44 years (7%). Furthermore, CKD is the 9th leading cause of death in the US. In 2017, over 500,000 patients received dialysis treatment, and over 200,000 lived with a kidney transplant according to the estimates released by the National Kidney Foundation Inc. Additionally, 746,557 Americans 2017 had kidney failure and needed dialysis to survive. Apart from that, in end-stage kidney disease (ESKD) nearly 125,000 people started ESKD treatment out of that 120,834 started dialysis as a treatment option to survive.
Global Kidney Dialysis Market Dynamics
Market Drivers
- Increasing prevalence of kidney disorders
- The growing geriatric population
- Growing awareness of the significance of early detection
- Issues concerning kidney transplants
Market Restraints
- High cost of dialysis equipment
- Complications with the dialysis procedure
Market Opportunities
- Rise in the prevalence of chronic health problems
- Shift in patient preference for home hemo-dialysis
Kidney Dialysis Market Report Coverage
| Market | Kidney Dialysis Market |
| Kidney Dialysis Market Size 2021 | USD 71.2 Billion |
| Kidney Dialysis Market Forecast 2030 | USD 116.1 Billion |
| Kidney Dialysis Market CAGR During 2022 - 2030 | 5.7% |
| Kidney Dialysis Market Analysis Period | 2018 - 2030 |
| Kidney Dialysis Market Base Year | 2021 |
| Kidney Dialysis Market Forecast Data | 2022 - 2030 |
| Segments Covered | By Product, By Application, By End-User, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | Baxter International Inc., Becton, Fresenius Medical Care AG & Co. KGaA, B. Braun, Nipro Corporation, Dickinson and Company, Nikkiso Co., Ltd., Medtronic plc, Cantel Medical Corporation, and Asahi Kasei Medical Co., Ltd. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Kidney Dialysis Market Insights
One of the major factors driving the global kidney dialysis market trend is the rising prevalence of kidney diseases. The World Health Organization (WHO) estimates that about 1.7 Billion people die every year as a result of acute kidney injury. As a result, an estimated 5-10 Billion people die every year as a result of kidney disease. However, the total number of people undergoing dialysis because of kidney failure has steadily increased from 19 Billion in 1990 to 33 Billion in 2013. According to Kidney Care UK estimates almost 30,000 people in the UK are on dialysis for treatment of acute kidney injury.
Government funding or initiative, on the other hand, fuels the market for dialysis treatment for patients with kidney failure. The Centers for Medicare & Medicaid Services (CMS) announced that the end-stage renal disease (ESRD) as a treatment option (ETC) Model has been finalized in order to increase or sustain the standard of care for patients with CKD by lowering expenditures. President Trump's Advancing Kidney Health Executive Order encouraged greater use of home dialysis and kidney transplantation to enhance the quality of life of Medicare beneficiaries with ESRD, and the ETC Model supports the such initiative. The ETC Model will represent nearly 30% of kidney care providers and will go into effect on January 1, 2021, with a savings estimate of US$ 23 Billion over five and a half years.
Kidney Dialysis Market Segmentation
The global kidney dialysis market segmentation is based on product, application, end-user, and geography.
Kidney Dialysis Market By Product
- Hemodialysis (HD) Equipment
- Concentrates & Solutions
- Peritoneal Dialysis (PD) Equipment
- Catheters & Tubings
- Others
According to the kidney dialysis industry analysis, the hemodialysis (HD) equipment segment will lead the total market under the product segment. One of the major factors driving the growth of the hemodialysis (HD) equipment segment that contributes to the global kidney dialysis market is the rising prevalence of terminal kidney failure among patients.
Kidney Dialysis Market By Application
- Hemodialysis
- Peritoneal Dialysis
In terms of application, hemodialysis will account for the largest market share in 2021. This expansion is linked to market maturity and is a popular method of treatment among healthcare experts and people suffering from ESPD.
Kidney Dialysis Market By End-User
- In-Center Dialysis Settings
- Home Care Settings
According to the kidney dialysis market forecast, the home dialysis segment would rise significantly in the next years. Home dialysis is predicted to be the fastest expanding category throughout the forecast period due to increased awareness and desire for home healthcare among dialysis patients.
Kidney Dialysis Market Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa
North America Dominates The Kidney Dialysis Market
Canada and the United States are predicted to dominate North America during the forecast period. The increase in the adoption of new technologies that pinpoint kidney dialysis equipment, as well as the presence of a large pool of prominent players, and the launch of new hemodialysis and peritoneal dialysis devices with various interventions, all have a positive impact on the global kidney dialysis market's growth. Furthermore, the growth of the kidney dialysis market share is fueled by growing public healthcare expenditure and increased awareness about available kidney treatment options. DaVita Healthcare Partners, Inc., Baxter International, Inc., Rockwell Medical, Inc., Becton, Dickinson, and Company, and Isopure Corp. are key players residing in the North American province highly involved in launching new products for dialysis to treat kidney disease.
On the other hand, Baxter International Inc. announced collaboration with Ayogo Health Inc. The collaboration launches a pilot of “CKD&Me” in several nephrology practices across the United States. These two firms have collaborated to create "CKD&Me," a one-of-a-kind app for smartphones and tablets that tailors instructional content to the individual learning needs of chronic kidney disease (CKD) patients. Kidney disease is associated with a tremendous economic burden. High-income countries typically spend more than 2-3% of their annual health care budget on the treatment of end-stage kidney disease, even though receiving such treatment represents under 0.03% of the total population.
In 2010, 2.62 Billion people received dialysis worldwide and the need for dialysis is projected to double by 2030 as per the World Health Organization (WHO). Additionally, in 2015, in the US Medicare expenditure on chronic and end-stage kidney disease was more than US$64 Bn respectively. Furthermore, according to a study released by the US Department of Health and Human Services (HHS), HHS is putting more emphasis on developing better capabilities to detect kidney disease early in high-risk patients and supporting new research to discover clinically useful biomarkers for better CKD detection. The CDC develops and maintains the national CKD surveillance system, which is the only interactive and detailed collection of CKD-related data in the United States that aids in monitoring performance toward national Healthy People goals. CDC continues to improve its understanding of kidney prevalence, risk factors, and health consequences by investing in the CKD surveillance system and conducting innovative epidemiological research.
Asia Pacific Will Register A Significant CAGR In The Forecast Period
With the extremely growing number of patients with end-stage renal disease, Asia-Pacific is projected to rise the quickest. This region is expected to see substantial growth in the number of kidney dialysis patients, resulting in overall market growth. According to the Saudi Journal of Kidney Diseases and Transplantation, as India's population grows beyond one billion, it is expected to become a major source of chronic diseases such as diabetes and hypertension. Since 25% of these people will develop CKD, the burden of end-stage renal disease (ESRD) will rise, and the healthcare system will have to deal with it.
Kidney Dialysis Market Players
Some of the top kidney dialysis market companies offered in the professional report includes Baxter International Inc., Becton, Fresenius Medical Care AG & Co. KGaA, B. Braun, Nipro Corporation, Dickinson and Company, Nikkiso Co., Ltd., Medtronic plc, Cantel Medical Corporation, and Asahi Kasei Medical Co., Ltd.
Frequently Asked Questions
The estimated value of global kidney dialysis market in 2021 was accounted to be USD 71.2 Billion.
The projected CAGR kidney dialysis market during the analysis period of 2022 to 2030 is 5.7%.
The prominent players of the global kidney dialysis market are Baxter International Inc., Becton, Fresenius Medical Care AG & Co. KGaA, B. Braun, Nipro Corporation, Dickinson and Company, Nikkiso Co., Ltd., Medtronic plc, Cantel Medical Corporation, and Asahi Kasei Medical Co., Ltd.
North America held the dominating kidney dialysis during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for kidney dialysis during the analysis period of 2022 to 2030.
Increasing prevalence of kidney disorders, and growing awareness of the significance of early detection, drives the growth of global kidney dialysis market.
Based on end-user, in-center dialysis settings segment is expected to hold the maximum share of the kidney dialysis market.
